WallStSmart

Haoxi Health Technology Limited Class A Ordinary Shares (HAO)vsWPP PLC ADR (WPP)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

WPP PLC ADR generates 41206% more annual revenue ($13.55B vs $32.80M). HAO leads profitability with a 11.8% profit margin vs -1.6%. HAO earns a higher WallStSmart Score of 42/100 (D).

HAO

Hold

42

out of 100

Grade: D

Growth: 4.0Profit: 5.0Value: 8.3Quality: 5.0

WPP

Avoid

35

out of 100

Grade: F

Growth: 2.0Profit: 3.0Value: 4.0Quality: 2.5
Piotroski: 3/9Altman Z: 0.73
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

HAOUndervalued (+98.0%)

Margin of Safety

+98.0%

Fair Value

$61.78

Current Price

$1.26

$60.52 discount

UndervaluedFair: $61.78Overvalued

Intrinsic value data unavailable for WPP.

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

HAO3 strengths · Avg: 9.7/10
P/E RatioValuation
0.9x10/10

Attractively priced relative to earnings

Price/BookValuation
0.2x10/10

Reasonable price relative to book value

Return on EquityProfitability
27.1%9/10

Every $100 of equity generates 27 in profit

WPP1 strengths · Avg: 8.0/10
Free Cash FlowQuality
$1.71B8/10

Generating 1.7B in free cash flow

Areas to Watch

HAO4 concerns · Avg: 2.8/10
EPS GrowthGrowth
1.7%4/10

1.7% earnings growth

Market CapQuality
$69.25M3/10

Smaller company, higher risk/reward

Revenue GrowthGrowth
-64.6%2/10

Revenue declined 64.6%

Free Cash FlowQuality
$-3.36M2/10

Negative free cash flow — burning cash

WPP4 concerns · Avg: 2.5/10
Operating MarginProfitability
2.2%3/10

Operating margin of 2.2%

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

PEG RatioValuation
4.232/10

Expensive relative to growth rate

Return on EquityProfitability
-5.3%2/10

ROE of -5.3% — below average capital efficiency

Comparative Analysis Report

WallStSmart Research

Bull Case : HAO

The strongest argument for HAO centers on P/E Ratio, Price/Book, Return on Equity.

Bull Case : WPP

The strongest argument for WPP centers on Free Cash Flow.

Bear Case : HAO

The primary concerns for HAO are EPS Growth, Market Cap, Revenue Growth.

Bear Case : WPP

The primary concerns for WPP are Operating Margin, Piotroski F-Score, PEG Ratio. Debt-to-equity of 2.13 is elevated, increasing financial risk.

Key Dynamics to Monitor

HAO profiles as a declining stock while WPP is a turnaround play — different risk/reward profiles.

WPP carries more volatility with a beta of 0.53 — expect wider price swings.

WPP is growing revenue faster at -8.3% — sustainability is the question.

WPP generates stronger free cash flow (1.7B), providing more financial flexibility.

Bottom Line

HAO scores higher overall (42/100 vs 35/100). Both earn "Hold" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Haoxi Health Technology Limited Class A Ordinary Shares

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

Haoxi Health Technology Limited Class A Ordinary Shares is a pioneering force in the health technology sector, committed to revolutionizing healthcare delivery through innovative solutions. Utilizing advanced technologies like artificial intelligence and data analytics, the company aims to enhance diagnosis, treatment efficiency, and patient management, setting new standards in healthcare practices. With a robust focus on research and development, Haoxi is well-positioned to capitalize on emerging trends in the healthcare technology landscape, presenting a significant growth opportunity for institutional investors.

WPP PLC ADR

COMMUNICATION SERVICES · ADVERTISING AGENCIES · USA

WPP plc, a creative transformation company, provides communications, expertise, trade and technology services in North America, the UK, Western Continental Europe, Asia Pacific, Latin America, Africa, the Middle East, and Central and Eastern Europe. The company is headquartered in London, the United Kingdom.

Visit Website →

Want to dig deeper into these stocks?